| Application no. and date | 17823017.3 (espacenet) (Federated) (European Patent Register), 20170929 | | Patent/reg. no. and date | DK/EP 3518932, 20241113 | | Publication date | 20190807 | | Priority no. and date | US 201662402004 P, 20160930, US 201662402150 P, 20160930 | | EP pub. no. and date |
EP 3518932 20190807 | | Effective date | | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045, JP,
Sumitomo Pharma Switzerland GmbH, Aeschengraben 27
Floor 22
4051 Basel, CH | | Applicant ref. no. | PN833269DKQ | | Inventor | JOHNSON, Brendan Mark, 2017 Markham Drive
Chapel Hill
North Carolina 27514, US,
SEELY, Lynn, 537 Occidental Avenue
San Mateo
California 94402, US,
RAJASEKHAR, Vijaykumar Reddy, 20200 Quail Hollow Road
Apple Valley
California, 92308, US,
MACLEAN, David B., 9 Stimpson Street
Middletown
Rhode Island 02842, US,
FAESSEL, Hélène M.,
Cambridge, MA 02142, US,
MUDD, Paul, N., 302 Beacon Falls Court
Cary
North Carolina 27519, US | | Representative | Marks & Clerk LLP, 44, rue de la Vallée
L-2661 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/513 (2006.01) , A61P 35/00 (2006.01) | | Title | BEHANDLING AF PROSTATACANCER | | Int. application no. | EP2017074849 | | Int. publication no. | WO2018060463 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
